Cargando…
Impact of Covid-19 on research and training in Parkinson's disease
The Coronavirus Disease 2019 (Covid-19) pandemic and the consequent restrictions imposed worldwide have posed an unprecedented challenge to research and training in Parkinson's disease (PD). The pandemic has caused loss of productivity, reduced access to funding, an oft-acute switch to digital...
Autores principales: | Wan, Yi-Min, van Wamelen, Daniel J., Lau, Yue Hui, Rota, Silvia, Tan, Eng-King |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066297/ https://www.ncbi.nlm.nih.gov/pubmed/36208905 http://dx.doi.org/10.1016/bs.irn.2022.04.003 |
Ejemplares similares
-
Parkinson's disease and Covid-19: The effect and use of telemedicine
por: Podlewska, Aleksandra M., et al.
Publicado: (2022) -
Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism
por: Leta, Valentina, et al.
Publicado: (2022) -
Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022) -
Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
por: Rota, Silvia, et al.
Publicado: (2022) -
Neurological research & training after the easing of lockdown in countries impacted by COVID-19
por: Tan, Eng-King, et al.
Publicado: (2020)